应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INVA Innoviva, Inc.
交易中 07-24 11:22:49 EDT
17.69
-0.13
-0.73%
最高
17.87
最低
17.63
成交量
7.87万
今开
17.82
昨收
17.82
日振幅
1.35%
总市值
11.05亿
流通市值
8.88亿
总股本
6,244万
成交额
139.54万
换手率
0.16%
流通股本
5,023万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Innoviva Inc 预计每股收益17美分 - 财报前瞻
Reuters · 05-03
Innoviva Inc 预计每股收益17美分 - 财报前瞻
Innoviva, Inc.盘中异动 快速拉升7.40%
自选股智能写手 · 03-01
Innoviva, Inc.盘中异动 快速拉升7.40%
Innoviva Inc 报告截至 12 月的季度业绩 - 收益摘要
Reuters · 03-01
Innoviva Inc 报告截至 12 月的季度业绩 - 收益摘要
Innoviva Inc 预计每股收益23美分 - 财报前瞻
Reuters · 02-23
Innoviva Inc 预计每股收益23美分 - 财报前瞻
公司概况
公司名称:
Innoviva, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Innoviva, Inc.于1996年11月在特拉华州注册,名为高级医药股份有限公司。公司于1997年5月开始运营。公司于2006年1月7日将名字改为Innoviva,是一家生物制药公司,拥有一系列自己发现的候选产品以及与制药公司的战略合作。公司集中于小分子药物的发现、开发和销售,用于诸多医疗领域,包括呼吸疾病、细菌感染、中枢神经系统疾病。其战略集中于发现、开发、销售高效的、便捷的、可容忍的、安全的药物。公司有其专有办法,结合化学和生物学,利用其在多价方面的知识,发现新的候选产品。
发行价格:
--
{"stockData":{"symbol":"INVA","market":"US","secType":"STK","nameCN":"Innoviva, Inc.","latestPrice":17.69,"timestamp":1721834564303,"preClose":17.82,"halted":0,"volume":78664,"delay":0,"floatShares":50225964,"shares":62444778,"eps":2.253156,"marketStatus":"交易中","marketStatusCode":2,"change":-0.13,"latestTime":"07-24 11:22:49 EDT","open":17.82,"high":17.87,"low":17.63,"amount":1395419.9093600002,"amplitude":0.013468,"askPrice":17.7,"askSize":274,"bidPrice":17.68,"bidSize":133,"shortable":3,"etf":0,"ttmEps":2.253156,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721851200000},"adr":0,"adjPreClose":17.82,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":17.82,"preClose":17.82,"latestTime":"16:03 EDT","volume":60690,"amount":1081495.8,"timestamp":1721765026004},"volumeRatio":0.354868,"impliedVol":0.5246,"impliedVolPercentile":0.8095},"requestUrl":"/m/hq/s/INVA/wiki","defaultTab":"wiki","newsList":[{"id":"2432511973","title":"Innoviva Inc 预计每股收益17美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432511973","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432511973?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:40","pubTimestamp":1714736422,"startTime":"0","endTime":"0","summary":" * Innoviva公司 预计将在5月7日公布截至2024年3月31日的业绩报告时显示季度收入下降() * 根据LSEG的数据,一位分析师预计,这家总部位于加利福尼亚州柏林厄姆的公司的营收将从去年同期的7637万美元下降11.0%,至6800.3万美元。* LSEG 的分析师平均预计 Innoviva Inc 每股收益为 17 美分。* 华尔街对 Innoviva Inc 的 12 个月目标价中位数为 15.00 美元,低于其上次收盘价 15.37 美元。5月3日 - 本摘要于北京时间 5 月 3 日 11:40 机器生成。除非另有说明,所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0},{"id":"2416641384","title":"Innoviva, Inc.盘中异动 快速拉升7.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416641384","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416641384?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:31","pubTimestamp":1709303513,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时31分,Innoviva, Inc.股票出现波动,股价急速拉升7.40%。Innoviva, Inc.股票所在的生物技术行业中,整体涨幅为0.86%。其相关个股中,Biovie Inc.、Adial Pharmaceuticals, Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃,换手率分别为950.68%、112.92%、64.05%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Ocean Biomedical Inc C/Wts 14/02/2028 、Biovie Inc.,振幅分别为29.41%、25.14%、22.57%。Innoviva, Inc.公司简介:Innoviva Inc在抗生素、呼吸系统和消化领域开发生物制药药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012231538af5df7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012231538af5df7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INVA"],"gpt_icon":0},{"id":"2416883176","title":"Innoviva Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2416883176","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416883176?lang=zh_cn&edition=full","pubTime":"2024-03-01 06:24","pubTimestamp":1709245447,"startTime":"0","endTime":"0","summary":" * Innoviva Inc 公布的截至12月底的季度调整后每股收益为76美分,高于去年同期的每股收益-98美分。* 收入同比增长 30.4%,达到 8584 万美元;分析师预期为 7552 万美元。* Innoviva Inc 股价本季度下跌了 4.3%。2月29日 - 预测变化 * 在过去三个月中,分析师的平均盈利预期没有变化。* 制药同行的平均一致建议也是 \"持有\"。华尔街对 Innoviva Inc 的 12 个月目标价中位数为 15.00 美元。本摘要由 LSEG 2 月 29 日 10:23 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA"],"gpt_icon":0},{"id":"2413751600","title":"Innoviva Inc 预计每股收益23美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413751600","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413751600?lang=zh_cn&edition=full","pubTime":"2024-02-23 19:13","pubTimestamp":1708686820,"startTime":"0","endTime":"0","summary":" * Innoviva公司 预计将在2月26日公布截至2023年12月31日的业绩报告。* LSEG 分析师对 Innoviva Inc 的平均预期为每股收益 23 美分。* 一位分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Innoviva Inc 的 12 个月目标价中位数为 15.00 美元,低于其上次收盘价 15.48 美元。2月23日 - 本摘要于北京时间2月23日11:13由机器生成。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inva.com","stockEarnings":[{"period":"1week","weight":0.0391},{"period":"1month","weight":0.1208},{"period":"3month","weight":0.1755},{"period":"6month","weight":0.0787},{"period":"1year","weight":0.348},{"period":"ytd","weight":0.111}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innoviva, Inc.于1996年11月在特拉华州注册,名为高级医药股份有限公司。公司于1997年5月开始运营。公司于2006年1月7日将名字改为Innoviva,是一家生物制药公司,拥有一系列自己发现的候选产品以及与制药公司的战略合作。公司集中于小分子药物的发现、开发和销售,用于诸多医疗领域,包括呼吸疾病、细菌感染、中枢神经系统疾病。其战略集中于发现、开发、销售高效的、便捷的、可容忍的、安全的药物。公司有其专有办法,结合化学和生物学,利用其在多价方面的知识,发现新的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.020373},{"month":2,"riseRate":0.444444,"avgChangeRate":0.029294},{"month":3,"riseRate":0.555556,"avgChangeRate":0.010593},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.024241},{"month":5,"riseRate":0.555556,"avgChangeRate":0.021053},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.007539},{"month":7,"riseRate":0.666667,"avgChangeRate":0.031582},{"month":8,"riseRate":0.375,"avgChangeRate":-0.039235},{"month":9,"riseRate":0.5,"avgChangeRate":-0.019483},{"month":10,"riseRate":0.5,"avgChangeRate":0.003074},{"month":11,"riseRate":0.625,"avgChangeRate":0.06919},{"month":12,"riseRate":0.875,"avgChangeRate":0.063312}],"exchange":"NASDAQ","name":"Innoviva, Inc.","nameEN":"Innoviva"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innoviva, Inc.(INVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innoviva, Inc.(INVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innoviva, Inc.,INVA,Innoviva, Inc.股票,Innoviva, Inc.股票老虎,Innoviva, Inc.股票老虎国际,Innoviva, Inc.行情,Innoviva, Inc.股票行情,Innoviva, Inc.股价,Innoviva, Inc.股市,Innoviva, Inc.股票价格,Innoviva, Inc.股票交易,Innoviva, Inc.股票购买,Innoviva, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innoviva, Inc.(INVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innoviva, Inc.(INVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}